pre-seed
Stage
1
Investors
About
mPATH provides an automated cancer screening navigation platform that improves screening completion rates by guiding patients through identification, education, and scheduling without adding staff, using patient-reported data to verify eligibility and coordinate follow-up.
Explore mPATH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.